Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
77 hedge funds and large institutions have $515M invested in Myovant Sciences Ltd. in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 22 closing their positions.
171% more capital invested
Capital invested by funds: $190M → $515M (+$325M)
55% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 22
50% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 16
18% more funds holding
Funds holding: 65 → 77 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
66% less call options, than puts
Call options by funds: $2.29M | Put options by funds: $6.84M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$20.2M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$8.76M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.59M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.04M |
| 5 |
VMI
VHCP Management III
New York
|
+$4.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$32.1M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$6.79M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$5.73M |
| 4 |
Bank of New York Mellon
New York
|
-$4.01M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.19M |
MYOV Hedge Fund Activity: Q4 2019 in Review
77 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2019, worth a combined $515M — up 171% from $190M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new MYOV positions and 22 closed out — a net gain of 12 holders — while 24 added to existing stakes and 16 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $20.2M. The largest seller was RA Capital Management, exiting entirely with an estimated $32.1M sold.
- 77 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2019, up from 65 in Q3 2019.
- Funds reported $515M of Myovant Sciences Ltd. stock for Q4 2019, up 171% quarter-over-quarter.
- 34 funds opened new Myovant Sciences Ltd. positions in Q4 2019 and 22 closed out, a net change of +12 holders.
- The largest Myovant Sciences Ltd. buyer in Q4 2019 was Cormorant Asset Management, an estimated $20.2M added.
- The largest Myovant Sciences Ltd. seller in Q4 2019 was RA Capital Management, an estimated $32.1M sold.
Based on aggregated 13F filings for Q4 2019.